ASX:NSB ASX Announcement 27 October 2026 Quarterly Activities Report for the Period Ended 30 September 2026 Highlights • Regulatory Engagement (US FDA Pre-IND Meeting): United States Food and Drug Administration (FDA) held a Pre-Investigational New Drug (Pre-IND) meeting to review NSB’s planned...
